Color

What Color does

Color Health, Inc. is a privately held, venture-backed healthcare delivery company headquartered in South San Francisco that operates a national, oncologist-led Virtual Cancer Clinic delivered through a 50-state licensed medical group, supplemented by a CAP-accredited, CLIA-certified clinical laboratory. Founded in 2015 by Othman Laraki, the company originally launched as Color Genomics with a low-cost hereditary cancer genetic test (BRCA1/BRCA2 plus 17 additional genes) at a fraction of traditional pricing, then expanded into population genomics (NIH All of Us genome center, WISDOM, PROMISE), public health scale-up during COVID-19, and ultimately pivoted its core focus to end-to-end cancer care. The current Virtual Cancer Clinic spans prevention, screening, diagnosis, treatment planning, active treatment, survivorship, and return-to-work support, and is the first virtual practice to earn ASCO Certified status from the American Society of Clinical Oncology (May 2026).

The platform integrates proprietary AI capabilities, including the Cancer Copilot (built with OpenAI's LLM and validated at UCSF at >95% concordance) for guideline-based clinical workup, the Color Assistant (built with Google Cloud) for breast cancer screening eligibility and follow-up, and the in-house LEAP machine-learning variant classifier and Universal Sequence Detection genotyper for clinical genomics. Underlying clinical operations are delivered through Color Medical, a wholly owned clinical services subsidiary, with at-home screening kits for HPV, FIT colorectal, PSA prostate, and hereditary cancer, plus the Cancer Connect peer-led support program. Customer scale includes 7M+ patients served, 26M+ healthcare interventions delivered, and 2,000+ organizations supported, with named enterprise customers spanning Hasbro, Hot Topic, Andersen Construction, Marsh McLennan Agency, Michael Baker International, Hunter Douglas, Schreiber Foods, Anywhere Real Estate, Crain, and Phillips 66, alongside union benefit funds such as Teamsters and health plan partners including Priority Health, Evry Health, and Collective Health.

Color's business model is anchored by multi-year enterprise B2B subscriptions of the Virtual Cancer Clinic sold to employers, health plans, unions, and public sector organizations (quote-based pricing with a 2.8:1 Year 1 ROI and 1:1 annual ROI guarantee), complemented by clinical lab-billed testing through CPT codes, direct-to-consumer test kit activation via home.color.com, and bundled partner distribution through Maven Clinic, Carrum Health, MSK Direct, and Collective Health. The company has raised approximately $480M+ in venture funding across rounds through 2022, including a $100M Series E in November 2021 led by Kindred Ventures and T. Rowe Price at a $4.6B post-money valuation. Recent strategic moves include the Oct 2024 launch of the Virtual Cancer Clinic with a 45+ organization rollout in Jan 2025, the Feb 2026 oncofertility partnership with Maven Clinic, the May 2026 ASCO Certified designation, and a 24,000 sq ft genomics lab lease at Kilroy Oyster Point Phase 2 with occupancy beginning early 2026.

Name

Color

Legal name

Color Health, Inc.

Website

https://color.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

251–500 employees

Short description

Color Health operates a national, ASCO Certified, oncologist-led Virtual Cancer Clinic delivered via a 50-state medical group and CAP-accredited lab, selling multi-year cancer care subscriptions to employers, health plans, unions, and public sector organizations with AI-augmented screening, diagnosis, and treatment support.

Ownership category

akta.pro rank

Product category

Cancer Care Delivery

NAICS

Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Oncology Telemedicine Platforms (HLALAGAH)

akta.pro secondary industry

Medical Oncology (HLAKAFAB)

Keywords

• Cancer care delivery
• Virtual cancer clinic
• Oncology care management
• Hereditary genetic testing
• Population health screening

Headquarters

HQ city

South San Francisco

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Enterprise Cancer Care Subscriptions: Recurring B2B contracts with employers, health plans, unions, and public sector organizations licensing Color's Virtual Cancer Clinic as a benefit, with a 2.8:1 Year 1 ROI and 1:1 annual ROI guarantee.
2. Clinical Genetic Testing (Hereditary Cancer, HPV, FIT, PSA): Clinical lab-billed testing services for hereditary cancer risk and population screening, delivered at-home via Color's CLIA-certified/CAP-accredited lab; billed through established clinical pathways and CPT codes aligned with health plan administration.
3. Direct-to-Consumer Test Kits: Activation of at-home genetic and cancer screening test kits through a self-serve portal (home.color.com/test/activate/start), including publicly-available breast cancer screening via Google.org social impact initiative.
4. AI Platform Partnerships: Revenue and value generated through strategic AI integrations with Google Cloud (Color Assistant) and OpenAI (Cancer Copilot), augmenting the core clinical offering.

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels10 records

Core offering

Color Health operates a national, ASCO Certified Virtual Cancer Clinic delivering oncologist-led direct clinical care across the full cancer journey — prevention, early detection and diagnosis, planning and active treatment, survivorship, and return to work — through a 50-state licensed medical group and a CAP-accredited, CLIA-certified laboratory. The platform is augmented by proprietary AI (Cancer Copilot built with OpenAI and Color Assistant built with Google Cloud) and bundles hereditary genetic testing, at-home screening kits, and peer-led survivorship support as an integrated employer, health plan, union, and public sector benefit.

Product overview

Color Health operates a single integrated cancer-care platform anchored by its Virtual Cancer Clinic, a national, ASCO Certified, oncologist-led virtual cancer center of excellence. The Virtual Cancer Clinic is the core offering and encompasses four integrated modules — Prevention/Early Detection/Diagnosis, Planning and Active Treatment, Survivorship Care and Return to Work, and Cancer Connect (peer-led support) — supported by the AI for Cancer Care suite, which includes the Color Assistant (Google Cloud AI agent for breast cancer screening) and Cancer Copilot (OpenAI-built clinical assistant for oncologists). Underlying the platform is the Color Medical clinical service, which provides the licensed 50-state medical group and operates a CAP-accredited, CLIA-certified laboratory delivering hereditary cancer genetic testing and at-home screening kits (HPV, FIT, PSA). The product architecture is a platform-plus-modules model: the Virtual Cancer Clinic is the unifying clinical program, with the AI capabilities and at-home diagnostic kits serving as embedded add-on modules, and the laboratory and clinical service as the operational backbone.

Differentiator

Problem solved

Functional benefit

Brands

• Virtual Cancer Clinic: Color's nationwide, oncologist-led virtual cancer center of excellence providing clinical cancer care from screening and diagnosis through treatment, survivorship, and return to work. ASCO Certified.
• Cancer Copilot
• Color Assistant
• Cancer Connect

Products and services

• Virtual Cancer Clinic National, ASCO Certified, oncologist-led virtual cancer center of excellence delivering direct clinical care across prevention, screening, diagnosis, treatment, survivorship, and return to work, sold to employers, health plans, unions, and public sector organizations as a bundled multi-year cancer benefit.
• AI for Cancer Care Suite of proprietary AI capabilities for cancer care delivery including the Cancer Copilot (LLM-based clinical assistant for oncologists) and the Color Assistant (generative AI agent for breast cancer screening eligibility and coordination), built with OpenAI and Google Cloud respectively.
• Hereditary Cancer Genetic Test Clinical genetic testing service analyzing 30+ genes related to hereditary cancer risk, including BRCA1/BRCA2, with at-home sample collection, pre- and post-test genetic counseling, and easy-to-understand reports. Available via clinician order, the Virtual Cancer Clinic, and direct-to-consumer activation.
• At-Home Cancer Screening Kits Self-administered at-home cancer screening kits covering HPV (cervical), Fecal Immunochemical Test/FIT (colorectal), PSA (prostate), and skin cancer, activated through Color's self-serve portal with physician oversight and follow-up coordination.

Quantifiable outcome

• 66% faster diagnosis (time to diagnosis cut by 66%, from months to days)
• +13 more outcomes

Named customers17 records

Segments7 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability9 records

Feature7 records

Partnerships

28 partnerships are on record, tiered minor, flagship and core.

• Waters CorporationminorStrategic or Co-development Partner · 8 April 2026Waters Corporation received FDA clearance for its Onclarity HPV Self-Collection Kit and announced a partnership with Color to expand at-home cervical cancer screening access in the United States.
• Maven ClinicflagshipStrategic or Co-development Partner · 12 February 2026First-of-its-kind oncofertility partnership to support family building after a cancer diagnosis. Integrates Color's oncologist-led cancer care with Maven's virtual women's and family health model. Eligible Color patients are routed into a dedicated Maven oncofertility pathway with access to oncologists, fertility specialists, and mental health providers for fertility preservation (egg, sperm, embryo freezing). Initially deployed through employers and health plans; Maven covers 28M lives across 2,000+ employer and health plan clients.
• Google CloudflagshipStrategic or Co-development Partner · 16 October 2025Partnership to expand access to breast cancer screening using an AI-powered virtual clinic called the Color Assistant, which helps determine eligibility and coordinate screenings for women aged 40 and older. Social impact initiative supported by Google.org, running through December 2025, and showcased in Google Cloud's ROI of AI in healthcare report.
• Hackensack Meridian HealthminorImplementation/ SI/ Consulting Partner · 16 October 2025Google Cloud and healthcare partners announced deployment of AI agents in hospitals, including at Hackensack Meridian Health and Color Health, on October 16, 2025, focusing on clinical-note summarization, breast-cancer screening, and prior-authorization.
• Conquer Cancer (ASCO Foundation)minorGTM or Marketing Partner · 10 June 2025Color Health supports the 2026 Conquer Cancer Young Investigator Award, providing a $50,000 grant to promote research in cancer survivorship. Applications opened on July 1, 2025.
• American Cancer Society (ACS)flagshipStrategic or Co-development Partner · 1 June 2023Partnership to operationalize cancer screening and prevention programs for employers and labor organizations, combining ACS's expertise with Color's population-scale healthcare delivery. Includes joint telehealth-based cancer screening programs for colorectal and lung cancer presented at ASCO 2025.
• NIH All of Us Research ProgramflagshipStrategic or Co-development Partner · 1 January 2018Color is one of three Clinical Validation Laboratories and the sole genetic counseling resource for the NIH's one-million-participant All of Us Research Program; Color analyzes and reports genomic data on a 59-gene panel covering breast/ovarian cancer, hypercholesterolemia, Lynch syndrome, and more. Over 80% of participants are from historically underrepresented populations.
• OpenAIflagshipTechnology or IntegrationCo-built Color's Cancer Copilot, an LLM-powered tool that combines large language models with cancer guideline knowledge bases to help oncologists and clinicians identify and order workup needs for recently diagnosed patients. Tested with UCSF, achieved >95% concordance on real-world patient cases; reduces a 2-hour clinical task to 10 minutes.
• Carrum HealthcoreStrategic or Co-development PartnerPartnership connects Color's proactive clinical care with Carrum's bundled Centers of Excellence network for cancer treatment. Together, they help employers deliver faster, clinically guided care from prevention through treatment and survivorship, reducing fragmentation and lowering costs.
• Memorial Sloan Kettering (MSK Direct)flagshipStrategic or Co-development PartnerCollaboration brings MSK Direct's world-class cancer care together with Color's nationwide Virtual Cancer Clinic, enabling employees everywhere to access timely diagnosis, treatment, and support regardless of location.
• Collective HealthcoreGTM or Marketing PartnerPartnership shifts cancer care from reactive to proactive. Members access Color's Virtual Cancer Clinic directly through the My Collective portal, with integrations that enable seamless care, eligibility tracking, and outcomes reporting.
• UCSFcoreImplementation/ SI/ Consulting PartnerPartner for testing and validation of the AI Cancer Copilot; co-authored the Color Health and UCSF AI Cancer Copilot study, achieving >95% concordance on real-world patient cases.
• WISDOM Trial (University of California, Sanford Health)coreStrategic or Co-development PartnerExclusive genomic testing partner for the 100,000-person WISDOM trial comparing annual mammograms to personalized, risk-based screening, expanding access to smarter breast cancer prevention strategies.
• PROMISE (Johns Hopkins and Fred Hutchinson Cancer Center)coreStrategic or Co-development PartnerColor provides clinical genetic testing for PROMISE, a national prostate cancer registry exploring the role of inherited mutations in outcomes and treatment, shaping new standards in prostate cancer care.
• GENTleMEN study (Fred Hutch, University of Washington)minorStrategic or Co-development PartnerColor collaborates with Fred Hutch and the University of Washington to expand access to genetic testing and counseling for men with advanced prostate cancer, removing cost and location as barriers.
• Case Western Reserve University (CAAPP)minorStrategic or Co-development PartnerCleveland African American Prostate Cancer Project (CAAPP) — partnership with barbershops across Cleveland and Case Western to help more Black men access hereditary cancer testing and counseling, reducing racial gaps in cancer detection.
• University of Michigan and Stanford (GIFT study)minorStrategic or Co-development PartnerGenetic Information and Family Testing (GIFT) study — gives cancer patients affordable genetic testing and personalized guidance to support their families, helping researchers understand what drives participation in family-based cancer prevention.
• Broad Institute of MIT and HarvardcoreStrategic or Co-development PartnerLong-standing research and precision medicine partner since 2018; together established one of three genome centers for the NIH All of Us Research Program.
• Mayo ClinicminorStrategic or Co-development PartnerResearch collaboration partner referenced in Color's history of working with leading research institutions.
• University of ChicagominorStrategic or Co-development PartnerResearch collaboration partner referenced in Color's history.
• Fred Hutchinson Cancer Research CentercoreStrategic or Co-development PartnerResearch and clinical partner on multiple studies, including the PROMISE prostate cancer registry and the GENTleMEN study for men with advanced prostate cancer.
• Evry HealthminorChannel Partner/ Reseller/ DistributorPartnership to bolster employer health plans with Color's Virtual Cancer Clinic, expanding access to virtual cancer care.
• Priority HealthminorChannel Partner/ Reseller/ DistributorPartnership to expand member access to Color's Virtual Cancer Clinic.
• HHS (U.S. Department of Health and Human Services)minorOthersFederal-level partnership referenced in Color's COVID-19 response; supported public health testing and vaccination efforts.
• City and County of San FranciscominorOthersPublic sector partnership — within one week of standing up its CLIA-certified COVID-19 lab, Color and the City and County of San Francisco launched one of the first high-capacity, public COVID testing sites.
• State of CaliforniacoreOthersState-level partnership — Color runs the State of California's HIV PrEP telehealth access program; also ran three-quarters of the country's state-level telehealth programs for antiviral COVID-19 treatment delivery.
• Commonwealth of MassachusettsminorOthersState-level partnership supporting COVID-19 testing and public health response.
• CDC (U.S. Centers for Disease Control and Prevention)minorOthersFederal-level partnership supporting COVID-19 testing, vaccination, and treatment services during the pandemic.

Scale indicators12 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Thyme Care: Thyme Care is a value-based virtual oncology care navigator and care manager serving health plans and providers. Directly comparable to Color's Virtual Cancer Clinic model — both deliver end-to-end cancer care navigation and management, though Thyme Care leans more on payer-side risk-bearing contracts while Color focuses on employer B2B subscriptions with direct oncologist-led clinical care.
• Carrum Health: Carrum Health is a value-based Centers of Excellence platform bundling surgical and cancer care for self-funded employers. Carrum is both a Color partner (via bundled cancer offerings) and a direct competitor in employer oncology benefits, with overlapping go-to-market into HR/benefits buyers and similar outcomes-based ROI guarantees.
• AccessHope (City of Hope / NCCN): AccessHope provides cancer expertise services to employers via remote tumor board reviews and expert opinions from NCI-designated centers. Directly comparable as a virtual cancer expertise offering sold to enterprise employers, though it focuses on expert advisory rather than Color's full clinical care delivery model.
• Memorial Sloan Kettering Direct (MSK Direct): MSK Direct is Memorial Sloan Kettering's employer-facing cancer care program providing expert navigation and access to MSK's cancer center. MSK Direct is both a Color partner and a direct competitor for employer oncology benefit spend, with deep brand authority in cancer care that Color must position against.
• Included Health: Included Health (formerly Doctor On Demand / Grand Rounds) is a virtual care platform serving employers and health plans across primary, behavioral, and specialty care including cancer navigation. Directly comparable as an enterprise virtual care vendor competing for the same benefits budget with broader (non-cancer-specific) scope.
• Transcarent: Transcarent is a virtual care platform serving self-funded employers with bundled specialty care including oncology navigation. Comparable as an enterprise virtual-care benefits vendor competing for the same employer buyer, though Transcarent is broader in scope and less oncology-specialized than Color.

Broad incumbents

• Tempus AI: Tempus is an AI-driven precision medicine company offering oncology genomic sequencing, data, and clinical decision support. Comparable as a broader AI/oncology incumbent with overlapping molecular profiling and clinical decision-support capabilities, though Tempus sells primarily to providers/pharma rather than employers.
• Flatiron Health: Flatiron Health (acquired by Roche) provides oncology-specific electronic health records, real-world evidence, and clinical trial technology to community oncology practices. Comparable as a broader oncology technology incumbent serving similar end users (oncologists, cancer centers) with overlapping data and clinical workflow capabilities.
• Natera: Natera is a genetic testing company with hereditary cancer panels (including BRCA testing) and oncology molecular residual disease testing. Directly comparable to Color's hereditary cancer genetic testing business as a broader genetic testing incumbent, though Natera is more provider-channel and lacks Color's full clinical care wrapper.
• Myriad Genetics: Myriad Genetics is a long-established hereditary cancer genetic testing company (BRACAnalysis, myRisk). Directly comparable to Color's original hereditary cancer genetic testing offering as an incumbent in the same category, though Myriad lacks Color's direct clinical care delivery and AI capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights8 records

Customer concentration

• Xx.com/color
• Facebookfacebook.com/color
• LinkedInlinkedin.com/company/color
• Instagraminstagram.com/Color

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries1 record

Funding overview

Funding rounds9 records

Investors23 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Color